EP2890687
Sölt af bensóþíasólonefnasambandi sem beta-2-adrenviðtakagerandefni
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
29.8.2013EP published:
28.6.2017EP application number:
13812075.3
EP translation filed:
31.7.2017Grant published:
15.8.2017EPO information:
European Patent Register
Max expiry date:
28.8.2033Expiry date:
28.8.2019
Title:
SALTS OF BENZOTHIAZOLONE COMPOUND AS BETA-2-ADRENOCEPTOR AGONIST
Timeline
Today
29.8.2013EP application
28.6.2017EP Publication
31.7.2017Translation submitted
15.8.2017Registration published
28.8.2019Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
GRANDEURY, ArnaudAddress:
Basel, CH
Name:
TUFILLI, NicolaAddress:
Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2392012Date:
30.8.2012Country:
IQ
Classification
Categories:
C07D 277/68, A61K 31/428, A61P 21/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 3.8.2017
Expires: 28.8.2018
Payer: Árnason Faktor
Number: 6
Paid: 25.7.2018
Expires: 28.8.2019
Payer: Árnason Faktor